Article Text
Letters to the editor
Use of cyclosporin A as a steroid sparing agent in cystic fibrosis
Statistics from Altmetric.com
Editor,—In cystic fibrosis (CF) chronic respiratory infection is countered by an intense inflammatory reaction. Systemic steroids have been shown to improve lung function and reduce morbidity in patients with CF and reduce markers of chronic inflammation1 ,2; however, there are significant side effects associated with their long term use. Low dose cyclosporin A (CyA) has been shown to be effective in the treatment of inflammatory and autoimmune diseases, corticosteroid dependent chronic severe asthma in adults, and refractory childhood asthma.3
We report six …